Company Data

Panbela Therapeutics Inc.

Ticker
PBLA
Current Price
$0.34 6.27%
Market Cap
$1.7M
Price Target
Refer to Report
Volume
27.5K
52wk Range
$0.3 - $1.5
Advanced Market Data

Overview

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy